PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA

Nasopharyngeal carcinoma is a rare tumor that accounts for 1-3% of all childhood malignancies. A 16-year-old patient with refractory nasopharyngeal carcinoma, whose treatment has to be interrupted due to COVID-19 positivity.After 6 weeks because of disease progression, we started his chemotherapy al...

Descripción completa

Detalles Bibliográficos
Autores principales: Şahin, Seda, Sarı, Neriman, Özyörük, Derya, Özdemir, Sonay İncesoy, Gülhan, Belgin, İlhan, İnci Ergürhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Editora Ltda. 2021
Materias:
RARE TUMOURS AND HISTIOCYTOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572567/
http://dx.doi.org/10.1016/j.htct.2021.10.1007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572567/
http://dx.doi.org/10.1016/j.htct.2021.10.1007

Ejemplares similares